CPT1A

carnitine palmitoyltransferase 1A

Basic information

Region (hg38): 11:68754620-68844410

Previous symbols: [ "CPT1" ]

Links

ENSG00000110090NCBI:1374OMIM:600528HGNC:2328Uniprot:P50416AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • carnitine palmitoyl transferase 1A deficiency (Strong), mode of inheritance: AR
  • carnitine palmitoyl transferase 1A deficiency (Strong), mode of inheritance: AR
  • carnitine palmitoyl transferase 1A deficiency (Supportive), mode of inheritance: AR
  • carnitine palmitoyl transferase 1A deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Carnitine palmitoyltransferase deficiency IARBiochemical; PharmacogenomicDietary management, including avoidance of fasting and prompt treatment of hypoglycemia, can prevent and treat metabolic decompensation, and can prevent neurologic damage; Surveillance for hepatic dysfunction may be beneficial, and potentially hepatoxic agents should be avoidedBiochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Renal7014807; 3211616; 1598098; 1403388; 9691089; 10625081; 11286380; 11350182; 12189492; 15110323; 20301700; 20696606; 21962599

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CPT1A gene.

  • Carnitine_palmitoyl_transferase_1A_deficiency (1001 variants)
  • not_provided (92 variants)
  • Inborn_genetic_diseases (86 variants)
  • not_specified (53 variants)
  • CPT1A-related_disorder (33 variants)
  • CPT1A_POLYMORPHISM (1 variants)
  • Metabolic_disease (1 variants)
  • CPT1A_ARCTIC_VARIANT (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPT1A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001876.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
11
clinvar
329
clinvar
5
clinvar
345
missense
6
clinvar
26
clinvar
248
clinvar
26
clinvar
3
clinvar
309
nonsense
25
clinvar
26
clinvar
5
clinvar
56
start loss
1
1
frameshift
31
clinvar
29
clinvar
3
clinvar
63
splice donor/acceptor (+/-2bp)
3
clinvar
33
clinvar
3
clinvar
39
Total 66 114 270 355 8

Highest pathogenic variant AF is 0.000331712

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CPT1Aprotein_codingprotein_codingENST00000265641 1889791
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.11e-91.001257030451257480.000179
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.643764770.7890.00003245079
Missense in Polyphen78136.080.573211424
Synonymous0.2841901950.9740.00001551486
Loss of Function3.432247.50.4630.00000278486

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002750.000275
Ashkenazi Jewish0.0009960.000993
East Asian0.0003260.000326
Finnish0.000.00
European (Non-Finnish)0.0001590.000149
Middle Eastern0.0003260.000326
South Asian0.0001960.000196
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion. Plays an important role in triglyceride metabolism.;
Disease
DISEASE: Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]: Rare autosomal recessive metabolic disorder of long- chain fatty acid oxidation characterized by severe episodes of hypoketotic hypoglycemia usually occurring after fasting or illness. Onset is in infancy or early childhood. {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:11441142, ECO:0000269|PubMed:12111367, ECO:0000269|PubMed:12189492, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:15110323, ECO:0000269|PubMed:15669684, ECO:0000269|PubMed:9691089}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Adipocytokine signaling pathway - Homo sapiens (human);Insulin resistance - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Long chain acyl-CoA dehydrogenase deficiency (LCAD);Trifunctional protein deficiency;Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids;Carnitine palmitoyl transferase deficiency (I);AMP-activated Protein Kinase (AMPK) Signaling;Fatty Acid Beta Oxidation;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);PPAR Alpha Pathway;Nuclear Receptors Meta-Pathway;RORA activates gene expression;Mitochondrial LC-Fatty Acid Beta-Oxidation;Leptin and adiponectin;PPAR signaling pathway;Liver steatosis AOP;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;Signal Transduction;mechanism of gene regulation by peroxisome proliferators via ppara;Circadian Clock;mitochondrial L-carnitine shuttle;Metabolism of lipids;Import of palmitoyl-CoA into the mitochondrial matrix;RORA activates gene expression;Metabolism;Fatty acid metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;FOXA2 and FOXA3 transcription factor networks (Consensus)

Recessive Scores

pRec
0.575

Intolerance Scores

loftool
0.0338
rvis_EVS
-0.48
rvis_percentile_EVS
22.78

Haploinsufficiency Scores

pHI
0.119
hipred
Y
hipred_score
0.639
ghis
0.494

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.976

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cpt1a
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype;

Gene ontology

Biological process
long-chain fatty acid metabolic process;glucose metabolic process;fatty acid beta-oxidation;triglyceride metabolic process;carnitine shuttle;circadian rhythm;carnitine metabolic process;response to organic cyclic compound;regulation of lipid metabolic process;epithelial cell differentiation;positive regulation of fatty acid beta-oxidation;response to drug;eating behavior;regulation of insulin secretion;protein homooligomerization;cellular response to fatty acid
Cellular component
mitochondrion;mitochondrial outer membrane;membrane;integral component of mitochondrial outer membrane
Molecular function
carnitine O-palmitoyltransferase activity;identical protein binding;palmitoleoyltransferase activity